Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Michael Pfreundschuh
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Disorders
Chemicals & Drugs
Procedures
Concepts & Ideas
Living Beings
Sign-in to see full Profile
Network (preview)
47
Diehl, Volker
43
Loeffler, Markus
37
Trümper, Lorenz
24
Hasenclever, Dirk
23
Gause, Angela
21
Sahin, Ugur
18
Kubuschok, Boris
17
Renner, C
16
Schmits, Rudolf
16
Daus, Heiner
15
Schmitz, Norbert
14
Pohl, C
13
Neumann, Frank
13
Renner, Christoph
13
Lathan, Bernd
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Michael Pfreundschuh (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Bernd Heinz-Wolfram; Ziepert Marita; Thorns Christoph; Klapper Wolfram; Wacker Hans-Heinrich; Hummel Michael; Stein Harald; Hansmann Martin-Leo; Ott German; Rosenwald Andreas; Müller-Hermelink Hans-Konrad; Barth Thomas F E; Möller Peter; Cogliatti Sergio B; Pfreundschuh Michael; Schmitz Norbert; Trümper Lorenz; Höller Silvia; Löffler Markus; Feller Alfred C;
Loss of HLA-DR expression and immunoblastic morphology predict adverse outcome in diffuse large B-cell lymphoma - analyses of cases from two prospective randomized clinical trials.
Haematologica 2009;94(11):1569-80.
-
2009: Grass Sandra; Preuss Klaus-Dieter; Ahlgrimm Manfred; Fadle Natalie; Regitz Evi; Pfoehler Claudia; Murawski Niels; Pfreundschuh Michael
Association of a dominantly inherited hyperphosphorylated paraprotein target with sporadic and familial multiple myeloma and monoclonal gammopathy of undetermined significance: a case-control study.
The lancet oncology 2009;10(10):950-6.
-
2009: Zwick Carsten; Preuss Klaus-Dieter; Kubuschok Boris; Held Gerhard; Ahlgrimm Manfred; Bittenbring Joerg; Schubert Joerg; Neumann Frank; Pfreundschuh Michael
Analysis of the antibody repertoire of patients with mantle cell lymphoma directed against mantle cell lymphoma-associated antigens.
Annals of hematology 2009;88(10):999-1003.
-
2009: Engert Andreas; Diehl Volker; Franklin Jeremy; Lohri Andreas; Dörken Bernd; Ludwig Wolf-Dieter; Koch Peter; Hänel Mathias; Pfreundschuh Michael; Wilhelm Martin; Trümper Lorenz; Aulitzky Walter-Erich; Bentz Martin; Rummel Mathias; Sezer Orhan; Müller-Hermelink Hans-Konrad; Hasenclever Dirk; Löffler Markus
Escalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkin's lymphoma: 10 years of follow-up of the GHSG HD9 study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(27):4548-54.
-
2009: Schoof N; von Bonin F; Zeynalova S; Ziepert M; Jung W; Loeffler M; Pfreundschuh M; Trümper L; Kube D
Favorable impact of the interleukin-4 receptor allelic variant I75 on the survival of diffuse large B-cell lymphoma patients demonstrated in a large prospective clinical trial.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2009;20(9):1548-54.
-
2009: Zwick Carsten; Held Gerhard; Hammermeister Vera; Alahmad Adnan; Kubuschok Boris; Bittenbring Joerg; Ahlgrimm Manfred; Neumann Frank; Preuss Klaus-Dieter; Pfreundschuh Michael
Spontaneous high-titered IgG antibody responses against BCL-2 in patients with aggressive lymphomas.
Journal of cancer research and clinical oncology 2009;135(9):1207-13.
-
2009: Leonard John P; Williams Michael E; Goy Andre; Grant Steven; Pfreundschuh Michael; Rosen Steve T; Sweetenham John W
Mantle cell lymphoma: biological insights and treatment advances.
Clinical lymphoma & myeloma 2009;9(4):267-77.
-
2009: Schmitz Norbert; Zeynalova Samira; Loeffler Markus; Pfreundschuh Michael;
Response: Intrathecal methotrexate and central nervous system events.
Blood 2009;114(9):1999-2000.
-
2009: Neumann Frank; Sturm Christine; Hülsmeyer Martin; Dauth Nina; Guillaume Philippe; Luescher Immanuel F; Pfreundschuh Michael; Held Gerhard
Fab antibodies capable of blocking T cells by competitive binding have the identical specificity but a higher affinity to the MHC-peptide-complex than the T cell receptor.
Immunology letters 2009;125(2):86-92.
-
2009: Preuss Klaus-Dieter; Pfreundschuh Michael; Ahlgrimm Manfred; Fadle Natalie; Regitz Evi; Murawski Niels; Grass Sandra
A frequent target of paraproteins in the sera of patients with multiple myeloma and MGUS.
International journal of cancer. Journal international du cancer 2009;125(3):656-61.
-
2009: Held Gerhard; Pfreundschuh Michael
Hematology: germinal center or nongerminal center DLBCL?
Nature reviews. Clinical oncology 2009;6(4):188-90.
-
2009: Boehme Volkmar; Schmitz Norbert; Zeynalova Samira; Loeffler Markus; Pfreundschuh Michael
CNS events in elderly patients with aggressive lymphoma treated with modern chemotherapy (CHOP-14) with or without rituximab: an analysis of patients treated in the RICOVER-60 trial of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL).
Blood 2009;113(17):3896-902.
-
2009: Herrmann Annina; Hoster Eva; Zwingers Thomas; Brittinger Günter; Engelhard Marianne; Meusers Peter; Reiser Marcel; Forstpointner Roswitha; Metzner Bernd; Peter Norma; Wörmann Bernhard; Trümper Lorenz; Pfreundschuh Michael; Einsele Hermann; Hiddemann Wolfgang; Unterhalt Michael; Dreyling Martin
Improvement of overall survival in advanced stage mantle cell lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(4):511-8.
-
2009: Assmann Gunter; Kueck Olaf; Kirchhoff Timm; Rosenthal Herbert; Voswinkel Jan; Pfreundschuh Michael; Zeidler Henning; Wagner Annette D
Efficacy of antibiotic therapy for SAPHO syndrome is lost after its discontinuation: an interventional study.
Arthritis research & therapy 2009;11(5):R140.
-
2009: Assmann Gunter; Werner Christian; Herrmann Markus; Momber Dunja; Krenn Thomas; Lothschütz Daniela; Fischer Lars; Hess Sandra; Ketter Ralf; Feiden Wolfgang; Jung Stefan; Herrmann Wolfgang; Schubert Jörg; Pfreundschuh Michael; Widmann Thomas
Detection of Meningeosis neoplastica by real-time quantitation of telomerase activity.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2009;47(10):1271-6.
-
2009: Pettengell Ruth; Aapro Matti; Brusamolino Ercole; Caballero Dolores; Coiffier Bertrand; Pfreundschuh Michael; Trneny Marek; Walewski Jan
Implications of the European Organisation for Research And Treatment Of Cancer (EORTC) guidelines on the use of granulocyte colony-stimulating factor (G-CSF) for lymphoma care.
Clinical drug investigation 2009;29(8):491-513.
-
2008: Jantunen Esa; Canals Carmen; Rambaldi Alessandro; Ossenkoppele Gert; Allione Bernardino; Blaise Didier; Conde Eulogio; Tilly Hervè; Cook Gordon; Clark Fiona; Gallamini Andrea; Haynes Andrew; Mounier Nicolas; Dreger Peter; Pfreundschuh Michael; Sureda Anna;
Autologous stem cell transplantation in elderly patients (> or =60 years) with diffuse large B-cell lymphoma: an analysis based on data in the European Blood and Marrow Transplantation registry.
Haematologica 2008;93(12):1837-42.
-
2008: Held Gerhard; Neumann Frank; Sturm Christine; Kaestner Lars; Dauth Nina; de Bruijn Diederik R; Renner Christoph; Lipp Peter; Pfreundschuh Michael
Differential presentation of tumor antigen-derived epitopes by MHC-class I and antigen-positive tumor cells.
International journal of cancer. Journal international du cancer 2008;123(8):1841-7.
-
2008: Zwick Carsten; Birkmann Josef; Peter Norma; Bodenstein Heinrich; Fuchs Roland; Hänel Mathias; Reiser Marcel; Hensel Manfred; Clemens Michael; Zeynalova Samira; Ziepert Marita; Pfreundschuh Michael;
Equitoxicity of bolus and infusional etoposide: results of a multicenter randomised trial of the German High-Grade Non-Hodgkins Lymphoma Study Group (DSHNHL) in elderly patients with refractory or relapsing aggressive non-Hodgkin lymphoma using the CEMP regimen (cisplatinum, etoposide, mitoxantrone and prednisone).
Annals of hematology 2008;87(9):717-26.
-
2008: Roehle Anja; Hoefig Kai P; Repsilber Dirk; Thorns Christoph; Ziepert Marita; Wesche Kai O; Thiere Marlen; Loeffler Markus; Klapper Wolfram; Pfreundschuh Michael; Matolcsy András; Bernd Heinz-Wolfram; Reiniger Lila; Merz Hartmut; Feller Alfred C
MicroRNA signatures characterize diffuse large B-cell lymphomas and follicular lymphomas.
British journal of haematology 2008;142(5):732-44.
-
2008: Werner Christian; Hanhoun Milad; Widmann Thomas; Kazakov Andrey; Semenov Alexander; Pöss Janine; Bauersachs Johann; Thum Thomas; Pfreundschuh Michael; Müller Patrick; Haendeler Judith; Böhm Michael; Laufs Ulrich
Effects of physical exercise on myocardial telomere-regulating proteins, survival pathways, and apoptosis.
Journal of the American College of Cardiology 2008;52(6):470-82.
-
2008: Held G; Schubert J; Pfreundschuh M
[Treatment of hematological malignancies with monoclonal antibodies]
Der Internist 2008;49(8):929-30, 932-4, 936-7.
-
2008: Kube Dieter; Hua Thanh-Duc; von Bonin Frederike; Schoof Nils; Zeynalova Samira; Klöss Marita; Gocht Daniela; Potthoff Bernd; Tzvetkov Mladen; Brockmöller Jürgen; Löffler Markus; Pfreundschuh Michael; Trümper Lorenz
Effect of interleukin-10 gene polymorphisms on clinical outcome of patients with aggressive non-Hodgkin's lymphoma: an exploratory study.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(12):3777-84.
-
2008: Hagenbeek Anton; Gadeberg Ole; Johnson Peter; Pedersen Lars Møller; Walewski Jan; Hellmann Andrzej; Link Brian K; Robak Tadeusz; Wojtukiewicz Marek; Pfreundschuh Michael; Kneba Michael; Engert Andreas; Sonneveld Pieter; Flensburg Mimi; Petersen Jørgen; Losic Nedjad; Radford John
First clinical use of ofatumumab, a novel fully human anti-CD20 monoclonal antibody in relapsed or refractory follicular lymphoma: results of a phase 1/2 trial.
Blood 2008;111(12):5486-95.
-
2008: Pfreundschuh Michael; Ho Anthony D; Cavallin-Stahl Eva; Wolf Max; Pettengell Ruth; Vasova Ingrid; Belch Andrew; Walewski Jan; Zinzani Pier-Luigi; Mingrone Walter; Kvaloy Stein; Shpilberg Ofer; Jaeger Ulrich; Hansen Mads; Corrado Claudia; Scheliga Adriana; Loeffler Markus; Kuhnt Evelyn;
Prognostic significance of maximum tumour (bulk) diameter in young patients with good-prognosis diffuse large-B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: an exploratory analysis of the MabThera International Trial Group (MInT) study.
The lancet oncology 2008;9(5):435-44.
-
2008: Ziepert M; Schmits R; Trümper L; Pfreundschuh M; Loeffler M;
Prognostic factors for hematotoxicity of chemotherapy in aggressive non-Hodgkin's lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(4):752-62.
-
2008: Trümper L; Zwick C; Ziepert M; Hohloch K; Schmits R; Mohren M; Liersch R; Bentz M; Graeven U; Wruck U; Hoffmann M; Metzner B; Hasenclever D; Loeffler M; Pfreundschuh M;
Dose-escalated CHOEP for the treatment of young patients with aggressive non-Hodgkin's lymphoma: I. A randomized dose escalation and feasibility study with bi- and tri-weekly regimens.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(3):538-44.
-
2008: Pfreundschuh M; Zwick C; Zeynalova S; Dührsen U; Pflüger K-H; Vrieling T; Mesters R; Mergenthaler H-G; Einsele H; Bentz M; Lengfelder E; Trümper L; Rübe C; Schmitz N; Loeffler M;
Dose-escalated CHOEP for the treatment of young patients with aggressive non-Hodgkin's lymphoma: II. Results of the randomized high-CHOEP trial of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(3):545-52.
-
2008: Pfreundschuh Michael; Schubert Joerg; Ziepert Marita; Schmits Rudolf; Mohren Martin; Lengfelder Eva; Reiser Marcel; Nickenig Christina; Clemens Michael; Peter Norma; Bokemeyer Carsten; Eimermacher Hartmut; Ho Anthony; Hoffmann Martin; Mertelsmann Roland; Trümper Lorenz; Balleisen Leopold; Liersch Ruediger; Metzner Bernd; Hartmann Frank; Glass Bertram; Poeschel Viola; Schmitz Norbert; Ruebe Christian; Feller Alfred C; Loeffler Markus;
Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60).
The lancet oncology 2008;9(2):105-16.
-
2008: Hoster Eva; Dreyling Martin; Klapper Wolfram; Gisselbrecht Christian; van Hoof Achiel; Kluin-Nelemans Hanneke C; Pfreundschuh Michael; Reiser Marcel; Metzner Bernd; Einsele Hermann; Peter Norma; Jung Wolfram; Wörmann Bernhard; Ludwig Wolf-Dieter; Dührsen Ulrich; Eimermacher Hartmut; Wandt Hannes; Hasford Joerg; Hiddemann Wolfgang; Unterhalt Michael;
A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma.
Blood 2008;111(2):558-65.
-
2008: Widmann Thomas; Kneer Harald; König Jochem; Herrmann Markus; Pfreundschuh Michael
Sustained telomere erosion due to increased stem cell turnover during triple autologous hematopoietic stem cell transplantation.
Experimental hematology 2008;36(1):104-10.
-
2008: Widmann Thomas; Sester Urban; Gärtner Barbara C; Schubert Jörg; Pfreundschuh Michael; Köhler Hans; Sester Martina
Levels of CMV specific CD4 T cells are dynamic and correlate with CMV viremia after allogeneic stem cell transplantation.
PloS one 2008;3(11):e3634.
-
2008: van Besien Koen; Gisselbrecht Christian; Pfreundschuh Michael; Zucca Emanuele
Secondary lymphomas of the central nervous system: risk, prophylaxis and treatment.
Leukemia & lymphoma 2008;49 Suppl 1():52-8.
-
2008: Bittenbring Joerg; Parisot Frédérique; Wabo Alain; Mueller Monika; Kerschenmeyer Lynn; Kreuz Markus; Truemper Lorenz; Landt Olfert; Menzel Alain; Pfreundschuh Michael; Roemer Klaus
MDM2 gene SNP309 T/G and p53 gene SNP72 G/C do not influence diffuse large B-cell non-Hodgkin lymphoma onset or survival in central European Caucasians.
BMC cancer 2008;8():116.
-
2007: Zwick Carsten; Gleissner Beate; Pfreundschuh Michael
Aspects of chemotherapy schedules in young and elderly patients with aggressive lymphoma.
Clinical lymphoma & myeloma 2007;8 Suppl 2():S43-9.
-
2007: Hess Sandra; Pfreundschuh Michael; Gleissner Beate
Notch signaling.
Journal of neurosurgery 2007;107(5):1060-1; author reply 1061-2.
-
2007: Engert Andreas; Franklin Jeremy; Eich Hans Theodor; Brillant Corinne; Sehlen Susanne; Cartoni Claudio; Herrmann Richard; Pfreundschuh Michael; Sieber Markus; Tesch Hans; Franke Astrid; Koch Peter; de Wit Maike; Paulus Ursula; Hasenclever Dirk; Loeffler Markus; Müller Rolf-Peter; Müller-Hermelink Hans Konrad; Dühmke Eckhart; Diehl Volker
Two cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine plus extended-field radiotherapy is superior to radiotherapy alone in early favorable Hodgkin's lymphoma: final results of the GHSG HD7 trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(23):3495-502.
-
2007: Held Gerhard; Wadle Andreas; Dauth Nina; Stewart-Jones Guillaume; Sturm Christine; Thiel Markus; Zwick Carsten; Dieckmann Detlef; Schuler Gerold; Hoogenboom Hennie R; Lévy Frédéric; Cerundolo Vincenzo; Pfreundschuh Michael; Renner Christoph
MHC-peptide-specific antibodies reveal inefficient presentation of an HLA-A*0201-restricted, Melan-A-derived peptide after active intracellular processing.
European journal of immunology 2007;37(7):2008-17.
-
2007: Preuss Klaus-Dieter; Held Gerhard; Kubuschok Boris; Hung Chun-Zhu; Malatsidze Natalia; Wagner Mathias; Pfreundschuh Michael
Identification of antigenic targets of paraproteins by expression cloning does not support a causal role of chronic antigenic stimulation in the pathogenesis of multiple myeloma and MGUS.
International journal of cancer. Journal international du cancer 2007;121(2):459-61.
-
2007: Widmann Thomas A; Herrmann Markus; Taha Naim; König Jochem; Pfreundschuh Michael
Short telomeres in aggressive non-Hodgkin's lymphoma as a risk factor in lymphomagenesis.
Experimental hematology 2007;35(6):939-46.
-
2007: Seil Inka; Frei Claudia; Sültmann Holger; Knauer Shirley K; Engels Knut; Jäger Elke; Zatloukal Kurt; Pfreundschuh Michael; Knuth Alexander; Tseng-Chen Yao; Jungbluth Achim A; Stauber Roland H; Jäger Dirk
The differentiation antigen NY-BR-1 is a potential target for antibody-based therapies in breast cancer.
International journal of cancer. Journal international du cancer 2007;120(12):2635-42.
-
2007: Hehlmann Rüdiger; Berger Ute; Pfirrmann Markus; Heimpel Hermann; Hochhaus Andreas; Hasford Joerg; Kolb Hans-Jochem; Lahaye Tanja; Maywald Ole; Reiter Andreas; Hossfeld Dieter K; Huber Christoph; Löffler Helmut; Pralle Hans; Queisser Wolfgang; Tobler Andreas; Nerl Christoph; Solenthaler Max; Goebeler Mariele E; Griesshammer Martin; Fischer Thomas; Kremers Stephan; Eimermacher Hartmut; Pfreundschuh Michael; Hirschmann Wolf-Dietrich; Lechner Klaus; Wassmann Barbara; Falge Christiane; Kirchner Hartmut H; Gratwohl Alois
Drug treatment is superior to allografting as first-line therapy in chronic myeloid leukemia.
Blood 2007;109(11):4686-92.
-
2007: Kube D; Hua T-D; Klöss M; Kulle B; Brockmöller J; Wojnowski L; Löffler M; Pfreundschuh M; Trümper L
The interleukin-10 gene promoter polymorphism -1087AG does not correlate with clinical outcome in non-Hodgkin's lymphoma.
Genes and immunity 2007;8(2):164-7.
-
2007: Pföhler Claudia; Preuss Klaus-Dieter; Tilgen Wolfgang; Stark Alexandra; Regitz Evi; Fadle Natalie; Pfreundschuh Michael
Mitofilin and titin as target antigens in melanoma-associated retinopathy.
International journal of cancer. Journal international du cancer 2007;120(4):788-95.
-
2007: Boehme V; Zeynalova S; Kloess M; Loeffler M; Kaiser U; Pfreundschuh M; Schmitz N;
Incidence and risk factors of central nervous system recurrence in aggressive lymphoma--a survey of 1693 patients treated in protocols of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(1):149-57.
-
2006: Held Gerhard; Schubert Joerg; Reiser Marcel; Pfreundschuh Michael;
Dose-intensified treatment of advanced-stage diffuse large B-cell lymphomas.
Seminars in hematology 2006;43(4):221-9.
-
2006: Nickenig Christina; Dreyling Martin; Hoster Eva; Pfreundschuh Michael; Trumper Lorenz; Reiser Marcel; Wandt Hannes; Lengfelder Eva; Unterhalt Michael; Hiddemann Wolfgang;
Combined cyclophosphamide, vincristine, doxorubicin, and prednisone (CHOP) improves response rates but not survival and has lower hematologic toxicity compared with combined mitoxantrone, chlorambucil, and prednisone (MCP) in follicular and mantle cell lymphomas: results of a prospective randomized trial of the German Low-Grade Lymphoma Study Group.
Cancer 2006;107(5):1014-22.
-
2006: Held Gerhard; Pöschel Viola; Pfreundschuh Michael
Rituximab for the treatment of diffuse large B-cell lymphomas.
Expert review of anticancer therapy 2006;6(8):1175-86.
-
2006: Wadle Andreas; Kubuschok Boris; Imig Jochen; Wuellner Beate; Wittig Christine; Zwick Carsten; Mischo Axel; Waetzig Kristin; Romeike Bernd F M; Lindemann Werner; Schilling Martin; Pfreundschuh Michael; Renner Christoph
Serological immune response to cancer testis antigens in patients with pancreatic cancer.
International journal of cancer. Journal international du cancer 2006;119(1):117-25.
-
2006: Pfreundschuh Michael; Trümper Lorenz; Osterborg Anders; Pettengell Ruth; Trneny Marek; Imrie Kevin; Ma David; Gill Devinder; Walewski Jan; Zinzani Pier-Luigi; Stahel Rolf; Kvaloy Stein; Shpilberg Ofer; Jaeger Ulrich; Hansen Mads; Lehtinen Tuula; López-Guillermo Armando; Corrado Claudia; Scheliga Adriana; Milpied Noel; Mendila Myriam; Rashford Michelle; Kuhnt Evelyn; Loeffler Markus;
CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group.
The lancet oncology 2006;7(5):379-91.
-
2006: Pfreundschuh Michael
Factors predictive for response of follicular and mantle-cell lymphoma to rituximab.
Nature clinical practice. Oncology 2006;3(4):184-5.
-
2006: Glass Bertram; Kloess Marita; Bentz Martin; Schlimok Günter; Berdel Wolfgang E; Feller Alfred; Trümper Lorenz; Loeffler Markus; Pfreundschuh Michael; Schmitz Norbert;
Dose-escalated CHOP plus etoposide (MegaCHOEP) followed by repeated stem cell transplantation for primary treatment of aggressive high-risk non-Hodgkin lymphoma.
Blood 2006;107(8):3058-64.
-
2006: Kubuschok Boris; Neumann Frank; Breit Rainer; Sester Martina; Schormann Claudia; Wagner Claudia; Sester Urban; Hartmann Frank; Wagner Mathias; Remberger Klaus; Schilling Martin; Pfreundschuh Michael
Naturally occurring T-cell response against mutated p21 ras oncoprotein in pancreatic cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(4):1365-72.
-
2006: Mischo Axel; Kubuschok Boris; Ertan Kubilay; Preuss Klaus-Dieter; Romeike Bernd; Regitz Evi; Schormann Claudia; de Bruijn Diederik; Wadle Andreas; Neumann Frank; Schmidt Werner; Renner Christoph; Pfreundschuh Michael
Prospective study on the expression of cancer testis genes and antibody responses in 100 consecutive patients with primary breast cancer.
International journal of cancer. Journal international du cancer 2006;118(3):696-703.
-
2006: Schmitz Nobert; Kloess Marita; Reiser Marcel; Berdel Wolfgang E; Metzner Bernd; Dorken Bernd; Kneba Michael; Trumper Lorenz; Loeffler Markus; Pfreundschuh Michael; Glass Bertram;
Four versus six courses of a dose-escalated cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) regimen plus etoposide (megaCHOEP) and autologous stem cell transplantation: early dose intensity is crucial in treating younger patients with poor prognosis aggressive lymphoma.
Cancer 2006;106(1):136-45.
-
2006: Preuss Klaus-Dieter; Regitz Evi; Neumann Frank; Pfreundschuh Michael
B-cell epitopes from the cancer testis antigen NY-ESO-1.
International journal of cancer. Journal international du cancer 2006;118(1):253.
-
2005: Wojnowski Leszek; Kulle Bettina; Schirmer Markus; Schlüter Gregor; Schmidt Albrecht; Rosenberger Albert; Vonhof Stefan; Bickeböller Heike; Toliat Mohammad Reza; Suk Eun-Kyung; Tzvetkov Mladen; Kruger Anke; Seifert Silvia; Kloess Marita; Hahn Heidi; Loeffler Markus; Nürnberg Peter; Pfreundschuh Michael; Trümper Lorenz; Brockmöller Jürgen; Hasenfuss Gerd
NAD(P)H oxidase and multidrug resistance protein genetic polymorphisms are associated with doxorubicin-induced cardiotoxicity.
Circulation 2005;112(24):3754-62.
-
2005: Wadle Andreas; Mischo Axel; Henrich Philipp P; Stenner-Liewen Frank; Scherer Christoph; Imig Jochen; Petersen Gabriele; Pfreundschuh Michael; Renner Christoph
Characterization of Hap/BAG-1 variants as RP1 binding proteins with antiapoptotic activity.
International journal of cancer. Journal international du cancer 2005;117(6):896-904.
-
2005: Pfreundschuh Michael
Mature T-cell and NK/T-cell neoplasms.
Clinical advances in hematology & oncology : H&O 2005;3(11):suppl 8-9.
-
2005: Neumann Frank; Wagner Claudia; Preuss Klaus-Dieter; Kubuschok Boris; Schormann Claudia; Stevanovic Stefan; Pfreundschuh Michael
Identification of an epitope derived from the cancer testis antigen HOM-TES-14/SCP1 and presented by dendritic cells to circulating CD4+ T cells.
Blood 2005;106(9):3105-13.
-
2005: Widmann Thomas Alexander; Willmann Barbara; Pfreundschuh Michael; Beelen Dietrich W
Influence of telomere length on short-term recovery after allogeneic stem cell transplantation.
Experimental hematology 2005;33(10):1257-61.
-
2005: Wadle Andreas; Mischo Axel; Imig Jochen; Wüllner Beate; Hensel Dan; Wätzig Kristin; Neumann Frank; Kubuschok Boris; Schmidt Werner; Old Lloyd J; Pfreundschuh Michael; Renner Christoph
Serological identification of breast cancer-related antigens from a Saccharomyces cerevisiae surface display library.
International journal of cancer. Journal international du cancer 2005;117(1):104-13.
-
2005: Liewen Heike; Meinhold-Heerlein Ivo; Oliveira Vasco; Schwarzenbacher Robert; Luo Guorong; Wadle Andreas; Jung Martin; Pfreundschuh Michael; Stenner-Liewen Frank
Characterization of the human GARP (Golgi associated retrograde protein) complex.
Experimental cell research 2005;306(1):24-34.
-
2005: Dinser Robert; Grgic Aleksandar; Kim Yoo-Jin; Pfreundschuh Michael; Schubert Jörg
Successful treatment of disseminated aspergillosis with the combination of voriconazole, caspofungin, granulocyte transfusions, and surgery followed by allogeneic blood stem cell transplantation in a patient with primary failure of an autologous stem cell graft.
European journal of haematology 2005;74(5):438-41.
-
2005: Schmits Rudolf; Schmitz Norbert; Pfreundschuh Michael;
The best treatment for diffuse large B-cell lymphoma: a German perspective.
Oncology (Williston Park, N.Y.) 2005;19(4 Suppl 1):16-25.
-
2005: Schmits R; Hartmann F; Pfreundschuh M
Advances in molecular biology diagnostic and treatment of B-cell malignancies.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16 Suppl 2():ii105.
-
2004: Schlapschy Martin; Gruber Helga; Gresch Oliver; Schäfer Claudia; Renner Christoph; Pfreundschuh Michael; Skerra Arne
Functional humanization of an anti-CD30 Fab fragment for the immunotherapy of Hodgkin's lymphoma using an in vitro evolution approach.
Protein engineering, design & selection : PEDS 2004;17(12):847-60.
-
2004: Neumann Frank; Wagner Claudia; Stevanovic Stefan; Kubuschok Boris; Schormann Claudia; Mischo Axel; Ertan Kubilay; Schmidt Werner; Pfreundschuh Michael
Identification of an HLA-DR-restricted peptide epitope with a promiscuous binding pattern derived from the cancer testis antigen HOM-MEL-40/SSX2.
International journal of cancer. Journal international du cancer 2004;112(4):661-8.
-
2004: Held Gerhard; Matsuo Mitsutoshi; Epel Malka; Gnjatic Sacha; Ritter Gerd; Lee Sang Yull; Tai Tsin Yee; Cohen Cyril J; Old Lloyd J; Pfreundschuh Michael; Reiter Yoram; Hoogenboom Hennie R; Renner Christoph
Dissecting cytotoxic T cell responses towards the NY-ESO-1 protein by peptide/MHC-specific antibody fragments.
European journal of immunology 2004;34(10):2919-29.
-
2004: Pfreundschuh Michael; Trümper Lorenz; Kloess Marita; Schmits Rudolf; Feller Alfred C; Rübe Christian; Rudolph Christian; Reiser Marcel; Hossfeld Dieter K; Eimermacher Hartmut; Hasenclever Dirk; Schmitz Norbert; Loeffler Markus;
Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL.
Blood 2004;104(3):634-41.
-
2004: Pfreundschuh Michael; Trümper Lorenz; Kloess Marita; Schmits Rudolf; Feller Alfred C; Rudolph Christian; Reiser Marcel; Hossfeld Dieter K; Metzner Bernd; Hasenclever Dirk; Schmitz Norbert; Glass Bertram; Rübe Christian; Loeffler Markus;
Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of young patients with good-prognosis (normal LDH) aggressive lymphomas: results of the NHL-B1 trial of the DSHNHL.
Blood 2004;104(3):626-33.
-
2004: Neumann Frank; Wagner Claudia; Kubuschok Boris; Stevanovic Stefan; Rammensee Hans-Georg; Pfreundschuh Michael
Identification of an antigenic peptide derived from the cancer-testis antigen NY-ESO-1 binding to a broad range of HLA-DR subtypes.
Cancer immunology, immunotherapy : CII 2004;53(7):589-99.
-
2004: Kubuschok Boris; Xie Xiaoxiun; Jesnowski Ralf; Preuss Klaus-Dieter; Romeike Bernd F M; Neumann Frank; Regitz Evi; Pistorius Georg; Schilling Martin; Scheunemann Peter; Izbicki Jakob R; Löhr J-Matthias; Pfreundschuh Michael
Expression of cancer testis antigens in pancreatic carcinoma cell lines, pancreatic adenocarcinoma and chronic pancreatitis.
International journal of cancer. Journal international du cancer 2004;109(4):568-75.
-
2004: Bauer Stefan; Adrian Nicole; Williamson Barbara; Panousis Con; Fadle Natalie; Smerd Joanna; Fettah Ilknur; Scott Andrew M; Pfreundschuh Michael; Renner Christoph
Targeted bioactivity of membrane-anchored TNF by an antibody-derived TNF fusion protein.
Journal of immunology (Baltimore, Md. : 1950) 2004;172(6):3930-9.
-
2003: Wagner Claudia; Neumann Frank; Kubuschok Boris; Regitz Evi; Mischo Axel; Stevanovic Stefan; Friedrich Michael; Schmidt Werner; Rammensee Hans-Georg; Pfreundschuh Michael
Identification of an HLA-A*02 restricted immunogenic peptide derived from the cancer testis antigen HOM-MEL-40/SSX2.
Cancer immunity : a journal of the Academy of Cancer Immunology 2003;3():18.
-
2003: Niemeyer Philipp; Türeci Ozlem; Eberle Thomas; Graf Norbert; Pfreundschuh Michael; Sahin Ugur
Expression of serologically identified tumor antigens in acute leukemias.
Leukemia research 2003;27(7):655-60.
-
2003: Mischo Axel; Wadle Andreas; Wätzig Kristin; Jäger Dirk; Stockert Elisabeth; Santiago Darren; Ritter Gerd; Regitz Evi; Jäger Elke; Knuth Alex; Old Lloyd; Pfreundschuh Michael; Renner Christoph
Recombinant antigen expression on yeast surface (RAYS) for the detection of serological immune responses in cancer patients.
Cancer immunity : a journal of the Academy of Cancer Immunology 2003;3():5.
-
2003: Diehl Volker; Franklin Jeremy; Pfreundschuh Michael; Lathan Bernd; Paulus Ursula; Hasenclever Dirk; Tesch Hans; Herrmann Richard; Dörken Bernd; Müller-Hermelink Hans-Konrad; Dühmke Eckhardt; Loeffler Markus;
Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease.
The New England journal of medicine 2003;348(24):2386-95.
-
2003: Wunderlich A; Kloess M; Reiser M; Rudolph C; Truemper L; Bittner S; Schmalenberg H; Schmits R; Pfreundschuh M; Loeffler M;
Practicability and acute haematological toxicity of 2- and 3-weekly CHOP and CHOEP chemotherapy for aggressive non-Hodgkin's lymphoma: results from the NHL-B trial of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(6):881-93.
-
2003: Xie Xiaoxun; Wacker Hans-Heinrich; Huang Shaoming; Regitz Evi; Preuss Klaus-Dieter; Romeike Bernd; Parwaresch Reza; Tiemann Markus; Pfreundschuh Michael
Differential expression of cancer testis genes in histological subtypes of non-Hodgkin's lymphomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(1):167-73.
-
2003: Krauss Jürgen; Arndt Michaela; Pfreundschuh Michael
Application of recombinant antibodies in cancer patients.
Methods in molecular biology (Clifton, N.J.) 2003;207():27-53.
-
2002: Huang Shaoming; Preuss Klaus-Dieter; Xie Xiaoxun; Regitz Evi; Pfreundschuh Michael
Analysis of the antibody repertoire of lymphoma patients.
Cancer immunology, immunotherapy : CII 2002;51(11-12):655-62.
-
2002: Sahin Ugur; Neumann Frank; Tureci Ozlem; Schmits Rudolf; Perez Franck; Pfreundschuh Michael
Hodgkin and Reed-Sternberg cell-associated autoantigen CLIP-170/restin is a marker for dendritic cells and is involved in the trafficking of macropinosomes to the cytoskeleton, supporting a function-based concept of Hodgkin and Reed-Sternberg cells.
Blood 2002;100(12):4139-45.
-
2002: Coiffier Bertrand; Pfreundschuh Michael; Stahel Rolf; Vose Julie; Zinzani Pier L
Aggressive lymphoma: improving treatment outcome with rituximab.
Anti-cancer drugs 2002;13 Suppl 2():S43-50.
-
2002: Kaiser Ulrich; Uebelacker Irmgard; Abel Ulrich; Birkmann Josef; Trümper Lorenz; Schmalenberg Harald; Karakas Tunca; Metzner Bernd; Hossfeld Dieter K; Bischoff Helge G; Franke Astrid; Reiser Marcel; Müller Peter; Mantovani Luisa; Grundeis Marc; Rothmann Frank; von Seydewitz Cay-Uwe; Mesters Rolf M; Steinhauer Ernst U; Krahl Dorothea; Schumacher Kurt; Kneba Michael; Baudis Michael; Schmitz Norbert; Pfab Rüdiger; Köppler Hubert; Parwaresch Reza; Pfreundschuh Michael; Havemann Klaus
Randomized study to evaluate the use of high-dose therapy as part of primary treatment for "aggressive" lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(22):4413-9.
-
2002: Trümper Lorenz; Menges Markus; Daus Heiner; Köhler Daniel; Reinhard Jan-Olaf; Sackmann Michael; Moser Cornelius; Sek Alexandra; Jacobs Georg; Zeitz Martin; Pfreundschuh Michael
Low sensitivity of the ki-ras polymerase chain reaction for diagnosing pancreatic cancer from pancreatic juice and bile: a multicenter prospective trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(21):4331-7.
-
2002: Preuss Klaus-Dieter; Zwick Carsten; Bormann Claudia; Neumann Frank; Pfreundschuh Michael
Analysis of the B-cell repertoire against antigens expressed by human neoplasms.
Immunological reviews 2002;188():43-50.
-
2002: Luo Guorong; Huang Shaoming; Xie Xiaoxun; Stockert Elisabeth; Chen Yao-Tseng; Kubuschok Boris; Pfreundschuh Michael
Expression of cancer-testis genes in human hepatocellular carcinomas.
Cancer immunity : a journal of the Academy of Cancer Immunology 2002;2():11.
-
2002: Türeci Ozlem; Sahin Ugur; Koslowski Michael; Buss Benedikt; Bell Carolin; Ballweber Pia; Zwick Carsten; Eberle Thomas; Zuber Margit; Villena-Heinsen Carlos; Seitz Gerhard; Pfreundschuh Michael
A novel tumour associated leucine zipper protein targeting to sites of gene transcription and splicing.
Oncogene 2002;21(24):3879-88.
-
2002: Kubuschok Boris; Schmits Rudolf; Hartmann Frank; Cochlovius Christiane; Breit Rainer; König Jochem; Pistorius Georg; Schilling Martin; Renner Christoph; Pfreundschuh Michael
Use of spontaneous Epstein-Barr virus-lymphoblastoid cell lines genetically modified to express tumor antigen as cancer vaccines: mutated p21 ras oncogene in pancreatic carcinoma as a model.
Human gene therapy 2002;13(7):815-27.
-
2002: Schmits Rudolf; Cochlovius Björn; Treitz Gerhard; Regitz Evi; Ketter Ralf; Preuss Klaus-Dieter; Romeike Bernd F M; Pfreundschuh Michael
Analysis of the antibody repertoire of astrocytoma patients against antigens expressed by gliomas.
International journal of cancer. Journal international du cancer 2002;98(1):73-7.
-
2002: Schmits R; Kubuschok B; Schuster S; Preuss K-D; Pfreundschuh M
Analysis of the B cell repertoire against autoantigens in patients with giant cell arteritis and polymyalgia rheumatica.
Clinical and experimental immunology 2002;127(2):379-85.
-
2002: Ayyoub Maha; Stevanovic Stefan; Sahin Ugur; Guillaume Philippe; Servis Catherine; Rimoldi Donata; Valmori Danila; Romero Pedro; Cerottini Jean-Charles; Rammensee Hans-Georg; Pfreundschuh Michael; Speiser Daniel; Lévy Frédéric
Proteasome-assisted identification of a SSX-2-derived epitope recognized by tumor-reactive CTL infiltrating metastatic melanoma.
Journal of immunology (Baltimore, Md. : 1950) 2002;168(4):1717-22.
-
2002: Sieber Markus; Tesch Hans; Pfistner Beate; Rueffer Ulrich; Lathan Bernd; Brosteanu Oana; Paulus Ursula; Koch Tina; Pfreundschuh Michael; Loeffler Markus; Engert Andreas; Josting Andreas; Wolf Jürgen; Hasenclever Dirk; Franklin Jeremy; Duehmke Eckhart; Georgii Axel; Schalk Klaus-Peter; Kirchner Hartmut; Doelken Gottfried; Munker Reinhold; Koch Peter; Herrmann Richard; Greil Richard; Anselmo Anna Paola; Diehl Volker
Rapidly alternating COPP/ABV/IMEP is not superior to conventional alternating COPP/ABVD in combination with extended-field radiotherapy in intermediate-stage Hodgkin's lymphoma: final results of the German Hodgkin's Lymphoma Study Group Trial HD5.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(2):476-84.
-
2001: Xie X; Schmits R; Renner C; Preuss D; Kubuschok B; Pfreundschuh M
Systematic search and molecular characterization of the antigenic targets of myeloma immunoglobulins: a monoclonal IgA from a female patient targeting sperm-specific cylicin II.
Cancer immunity : a journal of the Academy of Cancer Immunology 2001;1():11.
-
2001: Trümper L; Jung W; Daus H; Mechtersheimer G; von Bonin F; Pfreundschuh M
Assessment of clonality of rosetting T lymphocytes in Hodgkin's disease by single-cell polymerase chain reaction: detection of clonality in a polyclonal background in a case of lymphocyte predominance Hodgkin's disease.
Annals of hematology 2001;80(11):653-61.
-
2001: Wadle A; Thiel G; Mischo A; Jung V; Pfreundschuh M; Renner C
Chromosomal localization and promoter analysis of the adenomatous polyposis coli binding protein RP1.
Oncogene 2001;20(41):5920-9.
-
2001: Hartmann F; Jacobs G; Gotto H; Schwamborn J; Pfreundschuh M
Cytosine arabinoside, idarubicin and divided dose etoposide for the treatment of acute myeloid leukemia in elderly patients.
Leukemia & lymphoma 2001;42(3):347-55.
-
2001: Hartmann F; Renner C; Jung W; da Costa L; Tembrink S; Held G; Sek A; König J; Bauer S; Kloft M; Pfreundschuh M
Anti-CD16/CD30 bispecific antibody treatment for Hodgkin's disease: role of infusion schedule and costimulation with cytokines.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(7):1873-81.
-
2001: Dühmke E; Franklin J; Pfreundschuh M; Sehlen S; Willich N; Rühl U; Müller R P; Lukas P; Atzinger A; Paulus U; Lathan B; Rüffer U; Sieber M; Wolf J; Engert A; Georgii A; Staar S; Herrmann R; Beykirch M; Kirchner H; Emminger A; Greil R; Fritsch E; Koch P; Drochtert A; Brosteanu O; Hasenclever D; Loeffler M; Diehl V
Low-dose radiation is sufficient for the noninvolved extended-field treatment in favorable early-stage Hodgkin's disease: long-term results of a randomized trial of radiotherapy alone.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(11):2905-14.
-
2001: Renner C; Kubuschok B; Trümper L; Pfreundschuh M
Clinical approaches to vaccination in oncology.
Annals of hematology 2001;80(5):255-66.
-
2001: Renner C; Stehle I; Lee F T; Hall C; Catimel B; Nice E C; Mountain A; Rigopoulos A; Brechbiel M W; Pfreundschuh M; Scott A M
Targeting properties of an anti-CD16/anti-CD30 bispecific antibody in an in vivo system.
Cancer immunology, immunotherapy : CII 2001;50(2):102-8.
-
2001: Pfreundschuh M; Hasenclever D; Loeffler M; Ehninger G; Schmitz N; Kirchner H; Koch P; Lathan B; Rueffer U; Sextro M; Franklin J; Tesch H; Diehl V;
Dose escalation of cytotoxic drugs using haematopoietic growth factors: a randomized trial to determine the magnitude of increase provided by GM-CSF.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(4):471-7.
-
2001: Küpper M; Joos S; von Bonin F; Daus H; Pfreundschuh M; Lichter P; Trümper L
MDM2 gene amplification and lack of p53 point mutations in Hodgkin and Reed-Sternberg cells: results from single-cell polymerase chain reaction and molecular cytogenetic studies.
British journal of haematology 2001;112(3):768-75.
-
2001: Schmits R; Glass B; Trümper L; Pfreundschuh M;
Therapeutic strategies for aggressive lymphomas: the trials of the DSHNHL.
Annals of hematology 2001;80 Suppl 3():B77-83.
-
2001: Pfreundschuh M
Lymphoma 2000. The First International Symposium on Biology and Treatment of Aggressive Lymphomas: The stagnation seems to be over.
Annals of hematology 2001;80 Suppl 3():B1-2.
-
2000: Sahin U; Koslowski M; Türeci O; Eberle T; Zwick C; Romeike B; Moringlane J R; Schwechheimer K; Feiden W; Pfreundschuh M
Expression of cancer testis genes in human brain tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(10):3916-22.
-
2000: Kubuschok B; Cochlovius C; Jung W; Schmits R; Trümper L; Hartmann F; Renner C; Pfreundschuh M
Gene-modified spontaneous Epstein-Barr virus-transformed lymphoblastoid cell lines as autologous cancer vaccines: mutated p21 ras oncogene as a model.
Cancer gene therapy 2000;7(9):1231-40.
-
2000: Thorlacius H; Vollmar B; Guo Y; Mak T W; Pfreundschuh M M; Menger M D; Schmits R
Lymphocyte function antigen 1 (LFA-1) mediates early tumour necrosis factor alpha-induced leucocyte adhesion in venules.
British journal of haematology 2000;110(2):424-9.
-
2000: Renner C; Hartmann F; Jung W; Deisting C; Juwana M; Pfreundschuh M
Initiation of humoral and cellular immune responses in patients with refractory Hodgkin's disease by treatment with an anti-CD16/CD30 bispecific antibody.
Cancer immunology, immunotherapy : CII 2000;49(3):173-80.
-
2000: Stenner-Liewen F; Luo G; Sahin U; Tureci O; Koslovski M; Kautz I; Liewen H; Pfreundschuh M
Definition of tumor-associated antigens in hepatocellular carcinoma.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2000;9(3):285-90.
-
2000: Joos S; Küpper M; Ohl S; von Bonin F; Mechtersheimer G; Bentz M; Marynen P; Möller P; Pfreundschuh M; Trümper L; Lichter P
Genomic imbalances including amplification of the tyrosine kinase gene JAK2 in CD30+ Hodgkin cells.
Cancer research 2000;60(3):549-52.
-
2000: Pfreundschuh M
Exploitation of the B cell repertoire for the identification of human tumor antigens.
Cancer chemotherapy and pharmacology 2000;46 Suppl():S3-7.
-
1999: Arndt M A; Krauss J; Kipriyanov S M; Pfreundschuh M; Little M
A bispecific diabody that mediates natural killer cell cytotoxicity against xenotransplantated human Hodgkin's tumors.
Blood 1999;94(8):2562-8.
-
1999: Jacobs G; Tscholl E; Sek A; Pfreundschuh M; Daus H; Trümper L
Enrichment polymerase chain reaction for the detection of Ki-ras mutations: relevance of Taq polymerase error rate, initial DNA copy number, and reaction conditions on the emergence of false-positive mutant bands.
Journal of cancer research and clinical oncology 1999;125(7):395-401.
-
1999: Bauer S; Renner C; Juwana J P; Held G; Ohnesorge S; Gerlach K; Pfreundschuh M
Immunotherapy of human tumors with T-cell-activating bispecific antibodies: stimulation of cytotoxic pathways in vivo.
Cancer research 1999;59(8):1961-5.
-
1999: Juwana J P; Henderikx P; Mischo A; Wadle A; Fadle N; Gerlach K; Arends J W; Hoogenboom H; Pfreundschuh M; Renner C
EB/RP gene family encodes tubulin binding proteins.
International journal of cancer. Journal international du cancer 1999;81(2):275-84.
-
1999: Türeci O; Sahin U; Zwick C; Neumann F; Pfreundschuh M
Exploitation of the antibody repertoire of cancer patients for the identification of human tumor antigens.
Hybridoma 1999;18(1):23-8.
-
1998: Trümper L; Pfreundschuh M; Bonin F V; Daus H
Detection of the t(2;5)-associated NPM/ALK fusion cDNA in peripheral blood cells of healthy individuals.
British journal of haematology 1998;103(4):1138-44.
-
1998: Diehl V; Franklin J; Hasenclever D; Tesch H; Pfreundschuh M; Lathan B; Paulus U; Sieber M; Rueffer J U; Sextro M; Engert A; Wolf J; Hermann R; Holmer L; Stappert-Jahn U; Winnerlein-Trump E; Wulf G; Krause S; Glunz A; von Kalle K; Bischoff H; Haedicke C; Duehmke E; Georgii A; Loeffler M
BEACOPP, a new dose-escalated and accelerated regimen, is at least as effective as COPP/ABVD in patients with advanced-stage Hodgkin's lymphoma: interim report from a trial of the German Hodgkin's Lymphoma Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(12):3810-21.
-
1998: Tesch H; Diehl V; Lathan B; Hasenclever D; Sieber M; Rüffer U; Engert A; Franklin J; Pfreundschuh M; Schalk K P; Schwieder G; Wulf G; Dölken G; Worst P; Koch P; Schmitz N; Bruntsch U; Tirier C; Müller U; Loeffler M
Moderate dose escalation for advanced stage Hodgkin's disease using the bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine, and prednisone scheme and adjuvant radiotherapy: a study of the German Hodgkin's Lymphoma Study Group.
Blood 1998;92(12):4560-7.
-
1998: Hartmann F; Renner C; Jung W; Pfreundschuh M
Anti-CD16/CD30 bispecific antibodies as possible treatment for refractory Hodgkin's disease.
Leukemia & lymphoma 1998;31(3-4):385-92.
-
1998: Daus H; Ozbek C; Saage D; Scheller B; Schieffer H; Pfreundschuh M; Gause A
Lack of evidence for a pathogenic role of Chlamydia pneumoniae and cytomegalovirus infection in coronary atheroma formation.
Cardiology 1998;90(2):83-8.
-
1998: Türeci O; Chen Y T; Sahin U; Güre A O; Zwick C; Villena C; Tsang S; Seitz G; Old L J; Pfreundschuh M
Expression of SSX genes in human tumors.
International journal of cancer. Journal international du cancer 1998;77(1):19-23.
-
1998: Türeci O; Sahin U; Vollmar E; Siemer S; Göttert E; Seitz G; Parkkila A K; Shah G N; Grubb J H; Pfreundschuh M; Sly W S
Human carbonic anhydrase XII: cDNA cloning, expression, and chromosomal localization of a carbonic anhydrase gene that is overexpressed in some renal cell cancers.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(13):7608-13.
-
1998: Scanlan M J; Chen Y T; Williamson B; Gure A O; Stockert E; Gordan J D; Türeci O; Sahin U; Pfreundschuh M; Old L J
Characterization of human colon cancer antigens recognized by autologous antibodies.
International journal of cancer. Journal international du cancer 1998;76(5):652-8.
-
1998: Renner C; Trümper L; Pfitzenmeier J P; Loftin U; Gerlach K; Stehle I; Wadle A; Pfreundschuh M
Differential mRNA display at the single-cell level.
BioTechniques 1998;24(5):720-2, 724.
-
1998: Türeci O; Sahin U; Zwick C; Koslowski M; Seitz G; Pfreundschuh M
Identification of a meiosis-specific protein as a member of the class of cancer/testis antigens.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(9):5211-6.
-
1998: Mehl A M; Fischer N; Rowe M; Hartmann F; Daus H; Trümper L; Pfreundschuh M; Müller-Lantzsch N; Grässer F A
Isolation and analysis of two strongly transforming isoforms of the Epstein-Barr-Virus(EBV)-encoded latent membrane protein-1 (LMP1) from a single Hodgkin's lymphoma.
International journal of cancer. Journal international du cancer 1998;76(2):194-200.
-
1998: Diehl V; Franklin J; Hasenclever D; Tesch H; Pfreundschuh M; Lathan B; Paulus U; Sieber M; Rüffer J U; Sextro M; Engert A; Wolf J; Hermann R; Holmer L; Stappert-Jahn U; Winnerlein-Trump E; Wulf G; Krause S; Glunz A; von Kalle K; Bischoff H; Haedicke C; Dühmke E; Georgii A; Loeffler M
BEACOPP: a new regimen for advanced Hodgkin's disease. German Hodgkin's Lymphoma Study Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9 Suppl 5():S67-71.
-
1997: Renner C; Hartmann F; Pfreundschuh M
Treatment of refractory Hodgkin's disease with an anti-CD16/CD30 bispecific antibody.
Cancer immunology, immunotherapy : CII 1997;45(3-4):184-6.
-
1997: Gure A O; Türeci O; Sahin U; Tsang S; Scanlan M J; Jäger E; Knuth A; Pfreundschuh M; Old L J; Chen Y T
SSX: a multigene family with several members transcribed in normal testis and human cancer.
International journal of cancer. Journal international du cancer 1997;72(6):965-71.
-
1997: Renner C; Pfitzenmeier J P; Gerlach K; Held G; Ohnesorge S; Sahin U; Bauer S; Pfreundschuh M
RP1, a new member of the adenomatous polyposis coli-binding EB1-like gene family, is differentially expressed in activated T cells.
Journal of immunology (Baltimore, Md. : 1950) 1997;159(3):1276-83.
-
1997: Renner C; Held G; Ohnesorge S; Bauer S; Gerlach K; Pfitzenmeier J P; Pfreundschuh M
Role of naive and memory T cells in tumor cell lysis mediated by bi-specific antibodies.
Immunobiology 1997;197(1):122-32.
-
1997: Loeffler M; Diehl V; Pfreundschuh M; Rühl U; Hasenclever D; Nisters-Backes H; Sieber M; Tesch H; Franklin J; Geilen W; Bartels H; Cartoni C; Dölken G; Enzian J; Fuchs R; Gassmann W; Gerhartz H; Hagen-Aukamp U; Hiller E; Hinkelbein H; Hinterberger W; Kirchner H; Koch P; Krüger B; Schwarze E W
Dose-response relationship of complementary radiotherapy following four cycles of combination chemotherapy in intermediate-stage Hodgkin's disease.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(6):2275-87.
-
1997: Renner C; Held G; Ohnesorge S; Bauer S; Gerlach K; Pfitzenmeier J P; Pfreundschuh M
Role of perforin, granzymes and the proliferative state of the target cells in apoptosis and necrosis mediated by bispecific-antibody-activated cytotoxic T cells.
Cancer immunology, immunotherapy : CII 1997;44(2):70-6.
-
1997: Hartmann F; Renner C; Jung W; Deisting C; Juwana M; Eichentopf B; Kloft M; Pfreundschuh M
Treatment of refractory Hodgkin's disease with an anti-CD16/CD30 bispecific antibody.
Blood 1997;89(6):2042-7.
-
1997: Chen Y T; Scanlan M J; Sahin U; Türeci O; Gure A O; Tsang S; Williamson B; Stockert E; Pfreundschuh M; Old L J
A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(5):1914-8.
-
1997: Hartmann F; Pfreundschuh M
[Oncology '96]
Medizinische Klinik (Munich, Germany : 1983) 1997;92(2):83-100.
-
1997: Diehl V; Sieber M; Rüffer U; Lathan B; Hasenclever D; Pfreundschuh M; Loeffler M; Lieberz D; Koch P; Adler M; Tesch H
BEACOPP: an intensified chemotherapy regimen in advanced Hodgkin's disease. The German Hodgkin's Lymphoma Study Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(2):143-8.
-
1997: Gause A; Gundlach K; Carbon G; Daus H; Trümper L; Pfreundschuh M
Analysis of VH gene rearrangements from synovial B cells of patients with rheumatoid arthritis reveals infiltration of the synovial membrane by memory B cells.
Rheumatology international 1997;17(4):145-50.
-
1997: Trümper L; Daus H; Merz H; von Bonin F; Loftin U; Cochlovius C; Möller P; Feller A C; Pfreundschuh M
NPM/ALK fusion mRNA expression in Hodgkin and Reed-Sternberg cells is rare but does occur: results from single-cell cDNA analysis.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8 Suppl 2():83-7.
-
1996: Voswinkel J; Trümper L; Carbon G; Hopf T; Pfreundschuh M; Gause A
Evidence for a selected humoral immune response encoded by VH4 family genes in the synovial membrane of a patient with rheumatoid arthritis (RA).
Clinical and experimental immunology 1996;106(1):5-12.
-
1996: Türeci O; Sahin U; Schobert I; Koslowski M; Scmitt H; Schild H J; Stenner F; Seitz G; Rammensee H G; Pfreundschuh M
The SSX-2 gene, which is involved in the t(X;18) translocation of synovial sarcomas, codes for the human tumor antigen HOM-MEL-40.
Cancer research 1996;56(20):4766-72.
-
1996: Renner C; Ohnesorge S; Held G; Bauer S; Jung W; Pfitzenmeier J P; Pfreundschuh M
T cells from patients with Hodgkin's disease have a defective T-cell receptor zeta chain expression that is reversible by T-cell stimulation with CD3 and CD28.
Blood 1996;88(1):236-41.
-
1996: Hartmann F; Pfreundschuh M; Diehl V
[Prognosis and therapy of Hodgkin's disease]
Medizinische Klinik (Munich, Germany : 1983) 1996;91 Suppl 3():75-9.
-
1996: Pfreundschuh M
['94 oncology update]
Medizinische Klinik (Munich, Germany : 1983) 1996;91 Suppl 1():7-22.
-
1996: Renner C; Bauer S; Sahin U; Jung W; van Lier R; Jacobs G; Held G; Pfreundschuh M
Cure of disseminated xenografted human Hodgkin's tumors by bispecific monoclonal antibodies and human T cells: the role of human T-cell subsets in a preclinical model.
Blood 1996;87(7):2930-7.
-
1996: Trümper L; Pfreundschuh M; Jacobs G; von Bonin F; Loftin U; Möller P; Daus H
N-ras genes are not mutated in Hodgkin and Reed-Sternberg cells: results from single cell polymerase chain-reaction examinations.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1996;10(4):727-30.
-
1996: Koch B; Lemmermeier P; Gause A; v Wilmowsky H; Heisel J; Pfreundschuh M
Demonstration of interleukin-1beta and interleukin-6 in cells of synovial fluids by flow cytometry.
European journal of medical research 1996;1(5):244-8.
-
1996: Trümper L; Daus H; Gause A; Pfreundschuh M
Immunoglobulin V genes in Reed-Sternberg cells.
The New England journal of medicine 1996;334(6):404-5; author reply 405-6.
-
1996: Sahin U; Kraft-Bauer S; Ohnesorge S; Pfreundschuh M; Renner C
Interleukin-12 increases bispecific-antibody-mediated natural killer cell cytotoxicity against human tumors.
Cancer immunology, immunotherapy : CII 1996;42(1):9-14.
-
1996: Zdichavsky M; Schorpp C; Nickels A; Koch B; Pfreundschuh M; Gause A
Analysis of bcl-2+ lymphocyte subpopulations in inflammatory synovial infiltrates by a double-immunostaining technique.
Rheumatology international 1996;16(4):151-7.
-
1996: Hartmann F; Renner C; Jung W; Sahin U; Pfreundschuh M
Treatment of Hodgkin's disease with bispecific antibodies.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7 Suppl 4():143-6.
-
1996: Küpper M; Loftin U; von Bonin F; Gause A; Pfreundschuh M; Daus H; Trümper L
Single cell PCR for the analysis of Hodgkin's disease: four years later.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7 Suppl 4():35-9.
-
1995: Sahin U; Türeci O; Schmitt H; Cochlovius B; Johannes T; Schmits R; Stenner F; Luo G; Schobert I; Pfreundschuh M
Human neoplasms elicit multiple specific immune responses in the autologous host.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(25):11810-3.
-
1995: Diehl V; Loeffler M; Pfreundschuh M; Ruehl U; Hasenclever D; Nisters-Backes H; Sieber M; Smith K; Tesch H; Geilen W
Further chemotherapy versus low-dose involved-field radiotherapy as consolidation of complete remission after six cycles of alternating chemotherapy in patients with advance Hodgkin's disease. German Hodgkins' Study Group (GHSG).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1995;6(9):901-10.
-
1995: Renner C; Pfreundschuh M
Treatment of heterotransplanted Hodgkin's tumors in SCID mice by a combination of human NK or T cells and bispecific antibodies.
Journal of hematotherapy 1995;4(5):447-51.
-
1995: Gause A; Gundlach K; Zdichavsky M; Jacobs G; Koch B; Hopf T; Pfreundschuh M
The B lymphocyte in rheumatoid arthritis: analysis of rearranged V kappa genes from B cells infiltrating the synovial membrane.
European journal of immunology 1995;25(10):2775-82.
-
1995: Renner C; Jung W; Sahin U; van Lier R; Pfreundschuh M
The role of lymphocyte subsets and adhesion molecules in T cell-dependent cytotoxicity mediated by CD3 and CD28 bispecific monoclonal antibodies.
European journal of immunology 1995;25(7):2027-33.
-
1995: Daus H; Trümper L; Roth J; von Bonin F; Möller P; Gause A; Pfreundschuh M
Hodgkin and Reed-Sternberg cells do not carry T-cell receptor gamma gene rearrangements: evidence from single-cell polymerase chain reaction examination.
Blood 1995;85(6):1590-5.
-
1995: Pfreundschuh M
['94 oncology update]
Medizinische Klinik (Munich, Germany : 1983) 1995;90(3):144-59.
-
1994: Spickermann D; Gause A; Pfreundschuh M; Von Kalle A K; Bohlen H; Diehl V
Impaired antibody levels to tetanus toxoid and pneumococcal polysaccharides in acute leukemias.
Leukemia & lymphoma 1994;16(1-2):89-96.
-
1994: Jung W; Krueger S; Renner C; Gause A; Sahin U; Trümper L; Pfreundschuh M
Opposite effects of the CD30 ligand are not due to CD30 mutations: results from cDNA cloning and sequence comparison of the CD30 antigen from different sources.
Molecular immunology 1994;31(17):1329-34.
-
1994: Trümper L H; Bürger B; von Bonin F; Hintze A; von Blohn G; Pfreundschuh M; Daus H
Diagnosis of pancreatic adenocarcinoma by polymerase chain reaction from pancreatic secretions.
British journal of cancer 1994;70(2):278-84.
-
1994: Schrauder A; Gause A; Jung W; Mierau R; Pfreundschuh M
Persistence of a rheumatoid factor (RF)-producing B cell clone with a somatically mutated Ig kappa chain in a patient with rheumatoid arthritis.
Clinical and experimental immunology 1994;97(2):200-3.
-
1994: Roth J; Daus H; Trümper L; Gause A; Salamon-Looijen M; Pfreundschuh M
Detection of immunoglobulin heavy-chain gene rearrangement at the single-cell level in malignant lymphomas: no rearrangement is found in Hodgkin and Reed-Sternberg cells.
International journal of cancer. Journal international du cancer 1994;57(6):799-804.
-
1994: Fuchs R; Löffler M; Pfreundschuh M; Dölken G; Gerhartz H; Hagen-Aukamp U; Hiller E; Petsch S; Pflüger K H; Rühl U
Prognosis of high dose chemotherapy/autologous bone marrow transplantation candidates not receiving this treatment after failure of primary therapy of Hodgkin's disease.
Leukemia & lymphoma 1994;14(1-2):79-89.
-
1994: Renner C; Jung W; Sahin U; Denfeld R; Pohl C; Trümper L; Hartmann F; Diehl V; van Lier R; Pfreundschuh M
Cure of xenografted human tumors by bispecific monoclonal antibodies and human T cells.
Science (New York, N.Y.) 1994;264(5160):833-5.
-
1994: Schobert I; Renner C; Pfreundschuh M; Diehl V; Pohl C
Mimicry of the Hodgkin-associated IRAC antigen by an anti-idiotype network: potential use in active immunotherapy of Hodgkin's lymphoma.
Leukemia & lymphoma 1994;13(5-6):429-40.
-
1994: Pfreundschuh M G; Rueffer U; Lathan B; Schmitz N; Brosteanu O; Hasenclever D; Haas R; Kirchner H; Koch P; Kuse R
Dexa-BEAM in patients with Hodgkin's disease refractory to multidrug chemotherapy regimens: a trial of the German Hodgkin's Disease Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(3):580-6.
-
1994: Roth J; Daus H; Gause A; Trümper L; Pfreundschuh M
Detection of Epstein-Barr virus DNA in Hodgkin- and Reed-Sternberg-cells by single cell PCR.
Leukemia & lymphoma 1994;13(1-2):137-42.
-
1994: Trümper L; Jung W; Dahl G; Diehl V; Gause A; Pfreundschuh M
Interleukin-7, interleukin-8, soluble TNF receptor, and p53 protein levels are elevated in the serum of patients with Hodgkin's disease.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5 Suppl 1():93-6.
-
1993: Hombach A; Jung W; Pohl C; Renner C; Sahin U; Schmits R; Wolf J; Kapp U; Diehl V; Pfreundschuh M
A CD16/CD30 bispecific monoclonal antibody induces lysis of Hodgkin's cells by unstimulated natural killer cells in vitro and in vivo.
International journal of cancer. Journal international du cancer 1993;55(5):830-6.
-
1993: Hanisch F G; Heimbüchel G; Baldus S E; Uhlenbruck G; Schmits R; Pfreundschuh M; Schwonzen M; Vierbuchen M; Bara J; Peter-Katalinic J
Monoclonal antibody FW6 defines an epitope on alpha 3/4-monofucosylated polylactosaminoglycans expressed by fetal and colon carcinoma-associated mucins.
Cancer research 1993;53(18):4367-75.
-
1993: Renner C; Pfreundschuh M; Diehl V; Pohl C
Active specific immunotherapy of Hodgkin's lymphoma by an anti-idiotype vaccine against the Hodgkin-associated CD30 antigen.
Annals of the New York Academy of Sciences 1993;690():352-4.
-
1993: Pohl C; Renner C; Schwonzen M; Schobert I; Liebenberg V; Jung W; Wolf J; Pfreundschuh M; Diehl V
CD30-specific AB1-AB2-AB3 internal image antibody network: potential use as anti-idiotype vaccine against Hodgkin's lymphoma.
International journal of cancer. Journal international du cancer 1993;54(3):418-25.
-
1993: Lathan B; Pfreundschuh M; Diehl V
[Therapeutic strategies of Hodgkin's disease]
Der Internist 1993;34(2):146-54.
-
1992: Schwamborn J; Pfreundschuh M
[Update oncology '92. The age of meta-analysis]
Medizinische Klinik (Munich, Germany : 1983) 1992;87(12):646-60.
-
1992: Fuchs R; Löffler M; Pfreundschuh M; Dölken G; Gerhartz H; Hagen-Aukamp U; Hiller E; Petsch S; Pflüger K H; Rühl U
[Recurrence of Hodgkin's disease after advanced primary stages. German Hodgkin's Study Group]
Medizinische Klinik (Munich, Germany : 1983) 1992;87(11):555-62.
-
1992: da Costa L; Carde P; Lumbroso J D; Ricard M; Pfreundschuh M; Bosq J; Manil L; Diehl V; Parmentier C
Immunoscintigraphy in Hodgkin's disease and anaplastic large cell lymphomas: results in 18 patients using the iodine radiolabeled monoclonal antibody HRS-3.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1992;3 Suppl 4():53-7.
-
1992: Gause A; Jung W; Schmits R; Tschiersch A; Scholz R; Pohl C; Hasenclever D; Diehl V; Pfreundschuh M
Soluble CD8, CD25 and CD30 antigens as prognostic markers in patients with untreated Hodgkin's lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1992;3 Suppl 4():49-52.
-
1992: Pfreundschuh M; Lathan B; Löffler M; Rüffer U; Hasenclever D; Diehl V
The Second International Symposium on Hodgkin's Disease. Workshop III: Recommendations for future clinical trials.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1992;3 Suppl 4():101-4.
-
1992: Gause A; Jung W; Keymis S; Schobert I; Scholz R; Schmits R; Diehl V; Pohl C; Hasenclever D; Pfreundschuh M
The clinical significance of cytokines and soluble forms of membrane-derived activation antigens in the serum of patients with Hodgkin's disease.
Leukemia & lymphoma 1992;7(5-6):439-47.
-
1992: Schwonzen M; Pfreundschuh M; Pohl C; Schuh A; Lathan B; Diehl V
Binding of monoclonal anti-interleukin 2 antibody to nucleoli in acute leukemia blast cells.
Leukemia research 1992;16(6-7):589-95.
-
1992: Gause A; Keymis S; Scholz R; Schobert I; Jung W; Diehl V; Pohl C; Pfreundschuh M
Increased levels of circulating cytokines in patients with untreated Hodgkin's disease.
Lymphokine and cytokine research 1992;11(2):109-13.
-
1992: Schwamborn J; Pfreundschuh M
[Stepwise diagnosis of anemia]
Medizinische Klinik (Munich, Germany : 1983) 1992;87(4):188-97.
-
1992: Schwonzen M; Schmits R; Baldus S E; Vierbuchen M; Hanisch F G; Pfreundschuh M; Diehl V; Bara J; Uhlenbruck G
Monoclonal antibody FW6 generated against a mucin-carbohydrate of human amniotic fluid recognises a colonic tumour-associated epitope.
British journal of cancer 1992;65(4):559-65.
-
1992: Pohl C; Renner C; Schwonzen M; Sieber M; Lorenz P; Pfreundschuh M; Diehl V
Anti-idiotype vaccine against Hodgkin's lymphoma: induction of B- and T-cell immunity across species barriers against CD30 antigen by murine monoclonal internal image antibodies.
International journal of cancer. Journal international du cancer 1992;50(6):958-67.
-
1992: Schwamborn J; Pfreundschuh M
[Oncology update '91]
Medizinische Klinik (Munich, Germany : 1983) 1992;87(1):28-38.
-
1992: Gause A; Schmitz G; von Kalle A K; Lathan B; Diehl V; Pfreundschuh M
The clinical relevance of IgG subclasses in acute leukemias: low serum IgG as a risk factor for early death due to infection in acute myelogenous leukemia.
Leukemia research 1992;16(2):165-71.
-
1991: Gause A; Scholz R; Klein S; Jung W; Diehl V; Tesch H; Hasenclever D; Pfreundschuh M
Increased levels of circulating interleukin-6 in patients with Hodgkin's disease.
Hematological oncology 1991;9(6):307-13.
-
1991: Gause A; Verpoort K; Roschansky V; Tschiersch A; Hasenclever D; Schmits R; Diehl V; Brosteanu O; Pfreundschuh M
The clinical significance of serum CD8 antigen levels in adult patients with Hodgkin's disease.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1991;2(8):579-83.
-
1991: Gause A; Pohl C; Tschiersch A; Da Costa L; Jung W; Diehl V; Hasenclever D; Pfreundschuh M
Clinical significance of soluble CD30 antigen in the sera of patients with untreated Hodgkin's disease.
Blood 1991;77(9):1983-8.
-
1991: Pohl C; Sieber M; Diehl V; Pfreundschuh M
Idiotype vaccine against Hodgkin's lymphoma: generation and characterization of an anti-idiotypic monoclonal antibody against the Hodgkin-associated (anti-CD 30) monoclonal antibody HRS-3.
Anticancer research 1991;11(3):1115-24.
-
1991: Gause A; Roschansky V; Tschiersch A; Smith K; Hasenclever D; Schmits R; Diehl V; Pfreundschuh M
Low serum interleukin-2 receptor levels correlate with a good prognosis in patients with Hodgkin's lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1991;2 Suppl 2():43-7.
-
1990: Sahin U; Hartmann F; Senter P; Pohl C; Engert A; Diehl V; Pfreundschuh M
Specific activation of the prodrug mitomycin phosphate by a bispecific anti-CD30/anti-alkaline phosphatase monoclonal antibody.
Cancer research 1990;50(21):6944-8.
-
1990: Hiddemann W; Schmitz N; Pfreundschuh M; Pflüger K H; Ollech-Chwoyka J; Tirier C; Maschmeyer G; Kirchner H; Wagner T; Koch P
Treatment of refractory Hodgkin's disease with high-dose cytosine arabinoside and mitoxantrone in combination. Results of a clinical phase II study of the German Hodgkin Study Group.
Cancer 1990;66(5):838-43.
-
1990: Gause A; Pfreundschuh M
[Immunotherapy of malignant diseases using interleukin 2. Bases, results, trends]
Medizinische Klinik (Munich, Germany : 1983) 1990;85(9):561-6, 570.
-
1990: Pfreundschuh M; Pohl C; Berenbeck C; Schroeder J; Jung W; Schmits R; Tschiersch A; Diehl V; Gause A
Detection of a soluble form of the CD30 antigen in sera of patients with lymphoma, adult T-cell leukemia and infectious mononucleosis.
International journal of cancer. Journal international du cancer 1990;45(5):869-74.
-
1990: Carde P; Da Costa L; Manil L; Pfreundschuh M; Lumbroso J D; Saccavini J C; Caillou B; Ricard M; Boudet F; Hayat M
Immunoscintigraphy of Hodgkin's disease: in vivo use of radiolabelled monoclonal antibodies derived from Hodgkin cell lines.
European journal of cancer (Oxford, England : 1990) 1990;26(4):474-9.
-
1990: Diehl V; Pfreundschuh M; Löffler M; Rühl U; Hiller E; Gerhartz H; Kirchner H
Cooperative trials of Hodgkin's lymphoma in the Federal Republic of Germany.
Journal of cancer research and clinical oncology 1990;116(1):106-8.
-
1989: Schell-Frederick E; Tepass T; Lorscheidt G; Pfreundschuh M; Schaadt M; Diehl V
Effects of recombinant tumor necrosis factor (rHuTNF alpha) on human neutrophils and monocytes: in vitro, ex vivo and in vivo.
European journal of haematology 1989;43(4):286-96.
-
1989: Pfreundschuh M; Carde P; Da Costa L; Manil L; Lumbroso J D; Caillou B; Boudet F; Ricard M; Hayat M; Diehl V
[In vivo imaging of Hodgkin's lymphomas using monoclonal antibodies]
Onkologie 1989;12 Suppl 1():30-3.
-
1989: Pfreundschuh M; Genth B; Kirchner H; Scheurich P; Lindemann A; Steinmetz H T; Schaadt M; Diehl V
[Mechanism of resistance to tumor necrosis factor]
Onkologie 1989;12(3):128-30.
-
1989: Schaadt M; Burrichter H; Pfreundschuh M; Schell-Frederick E; Tesch H; Fonatsch C; Stein H; Diehl V
Biology of Hodgkin cell lines.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1989;117():53-61.
-
1989: Armitage J O; Barnett M J; Carella A M; Dicke K A; Diehl V; Gribben J G; Pfreundschuh M
Bone marrow transplantation in the treatment of Hodgkin's lymphoma: problems, remaining challenges, and future prospects.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1989;117():246-53.
-
1989: Loeffler M; Pfreundschuh M; Rühl U; Hiller E; Gerhartz H; Roloff R; Adler M; Schoppe W; Hagen-Aukamp U; Schmitt G
Risk factor adapted treatment of Hodgkin's lymphoma: strategies and perspectives.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1989;117():142-62.
-
1989: Schwonzen M; Kuehn N; Vetten B; Diehl V; Pfreundschuh M
Phenotyping of acute myelomonocytic (AMMOL) and monocytic leukemia (AMOL): association of T-cell-related antigens and skin-infiltration in AMOL.
Leukemia research 1989;13(10):893-8.
-
1989: Carde P; Pfreundschuh M; da Costa L; Manil L; Lumbroso J D; Caillou B; Parmentier C; Saccavini J C; Diehl V
Radiolabeled monoclonal antibodies against Reed-Sternberg cells for in vivo imaging of Hodgkin's disease by immunoscintigraphy.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1989;117():101-11.
-
1989: Diehl V; Pfreundschuh M; Löffler M; Rühl U; Hiller E; Gerhartz H; Wilmanns W; Kirchner H; Schoppe W; Petsch S
Chemotherapy of Hodgkin's lymphoma with alternating cycles of COPP (cyclophosphamide, vincristin, procarbazine, prednisone) and ABVD (doxorubicin, bleomycin, vinblastine and dacarbazine). Results of the HD1 and HD3 trials of the German Hodgkin Study Group.
Medical oncology and tumor pharmacotherapy 1989;6(2):155-62.
-
1988: Loeffler M; Pfreundschuh M; Hasenclever D; Hiller E; Gerhartz H; Wilmanns W; Rohloff R; Rühl U; Kühn G; Fuchs R
Prognostic risk factors in advanced Hodgkin's lymphoma. Report of the German Hodgkin Study Group.
Blut 1988;56(6):273-81.
-
1988: Pfreundschuh M; Löffler M; Rühl U; Hiller E; Gerhartz H; Wilmanns W; Kirchner H; Schoppe W; Petsch S; Bartels H
[Therapy of Hodgkin's lymphomas. Results of the German Hodgkin's Disease Study Group]
Onkologie 1988;11(1):48-52.
-
1987: Pfreundschuh M G; Schoppe W D; Fuchs R; Pflüger K H; Loeffler M; Diehl V
Lomustine, etoposide, vindesine, and dexamethasone (CEVD) in Hodgkin's lymphoma refractory to cyclophosphamide, vincristine, procarbazine, and prednisone (COPP) and doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD): a multicenter trial of the German Hodgkin Study Group.
Cancer treatment reports 1987;71(12):1203-7.
-
1987: Diehl V; Pfreundschuh M; Löffler M; Smith K; Rühl U; Georgii A; Hiller E; Gerhartz H
[Therapy studies of the German Hodgkin's Study Group. Intermediate results of the study protocols HD1, HD2, and HD3]
Onkologie 1987;10(2):62-6.
-
1986: Diehl V; Pfreundschuh M; Hauser F E; Löffler M; Rühl U; Brücher H; Georgii A; Hiller E; Gerhartz H
[Intermediate results of therapy studies HD1, HD2 and HD3 of the German Hodgkin Study Group]
Medizinische Klinik (Munich, Germany : 1983) 1986;81(1):1-6.
Sign-in to see more
